2000 . Characterization of two alpha-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease . Biochim Biophys Acta 1501 : 227 – 235 .Kase R, Bierfreund U, Klein A, et al (2000) Characterization of two α-galactosidase mutants (Q279E and R301Q) found ...
alpha-Galactosidase ,98%NLT CAS 9031-11-2 MDL MFCD01092682 Enquiry sales@hairuichem.comDescription Related Intermediates Cat.No. HR130204 Chemical Name alpha-Galactosidase CAS 9031-11-2 MDL MFCD01092682Related Products HR138999 6258-30-6 4-CHLORO-α,α-DIMETHYLPHENYLACETIC ACID HR234000 ...
戊戌数据药品标准数据库提供了Alpha Galactosidase A马丁代尔药物大典标准的查询检索,包括Alpha Galactosidase A马丁代尔药物大典的版本Martindale38th页码,以及药典的查询与下载.
Background: Treatment of Fabry disease (FD) with recombinant alpha-galactosidase A (r-alpha GAL A) is complicated by the formation of anti-drug antibodies in the majority of male patients with the classical disease phenotype. Detailed information regarding antibody subtypes, onset and persistence of...
Protein structure-function relationships can be studied by using linker insertion mutagenesis, which efficiently identifies essential regions in target proteins. Bacteriophage Mu in vitro DNA transposition was used to generate an extensive library of pentapeptide insertion mutants within the -complementing doma...
- 1996 - 642 - www.ingentaconnect.com
Dommes. A late blight resistant potato plant overexpresses a gene coding for α-galactosidase upon infection by Phytophthora infestans[J]. Biologia Plantarum . 2006 (2)Evers D, Ghislain M, Hoffmann L, Hausman JF, Dommes J (2006) A late blight resistant potato plant overexpresses a gene...
Guo, "Human alpha galactosidase and alpha 1,2 fucosyltransferase concordantly inhibit xenoreact- ivity of NIH 3T3 cells with human serum," Acta Pharmacologica Sinica, vol. 24, no. 9, pp. 878-884, 2003.YAN, J.L., YU, L.Y., and GUO, L.H. (2003). Human alpha galactosi- dase and...
Disclosed polymer protein structure shows improved performance, according under the active and/or longer long-lasting activity lysosomal conditions of enhancing and in both serum environment.Avidor ShulmanIlya RuderferTehila Ben-MosheTalia ShekhterYaniv AzulayTali KizhnerYoseph Shaaltiel...
Patent InfringementNo Abstract available for this article.doi:10.2165/00126839-200304020-00006Drugs in R &Springer International PublishingDrugs in R & DNA;. (2003) Alpha-Galactosidase ??? Genzyme General. Drugs in R & D 4 , 115-118 /